Table 1 |
||||
|
Surface epitope phenotype of bone marrow-, tonsil-, muscle-, and dental pulp-derived mesenchymal progenitor cells* |
||||
|
BM-MPCs |
T-MPCs |
M-MPCs |
DP-MPCs |
|
|
|
||||
|
CD14 |
- |
- |
- |
- |
|
CD34 |
- |
- |
- |
- |
|
CD45 |
- |
- |
- |
- |
|
CD73 |
+ |
+ |
+ |
+ |
|
CD90 |
+ |
+ |
+ |
+ |
|
CD105 |
+ |
+ |
+ |
+ |
|
|
||||
|
*Surface epitopes or CD markers identified on the basis of immuoreactivity analyzed by fluorescence-activated cell sorting (FACS). FACS analysis showed that more than 95% of these cells were negative (-) for the expression of CD14, CD34, and CD45, and were positive (+) for CD73, CD90 and, CD105. Controls consisted of fluorescence observed with isotypic controls. BM, bone marrow; DP, dental pulp; M, muscle; MPC, mesenchymal progenitor cell; T, tonsil. |
||||
|
Djouad et al. Stem Cell Research & Therapy 2010 1:11 doi:10.1186/scrt11 |
||||